Anthos Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of genetically and pharmacologically validated innovative therapies to advance care for people living with cardiovascular and metabolic (CVM) diseases. Anthos Therapeutics aims to combine the agility of a biotech with the rigor of a large pharmaceutical company. Anthos Therapeutics was launched by Blackstone Life Sciences in 2019.
| Website | http://www.anthostherapeutics.com |
| Employees | 13 (10 on RocketReach) |
| Address | 55 Cambridge Pkwy 103, Cambridge, Massachusetts 02142, US |
| Phone | +1 617-430-6940 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+15 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Biopharmaceutical, Metabolic Diseases, Cardiovascular Health, Metabolic Health, Drug Development, Biotechnology, Drug Discovery, Clinical Stage, Innovative Therapies, Pharmaceutical Research, Therapeutic Solutions, Genetic Therapies, Life Sciences, Advanced Therapies, Clinical Trials, Health Technology, Precision Medicine, New Drug Applications |
| Competitors | Amgen, Bristol Myers Squibb, Pfizer, Novartis, AstraZeneca, Merck & Co., Inc., Roche, Sanofi, GSK, Johnson & Johnson +42 more (view full list) |
Looking for a particular Anthos Therapeutics employee's phone or email?
David McIntyre is the CFO of Anthos Therapeutics.
10 people are employed at Anthos Therapeutics.
Anthos Therapeutics is based in Cambridge, Massachusetts.